Off-Label Use of Recombinant Human Factor VIIa
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery
Reference16 articles.
1. Current status of pharmacologic therapies in patient blood management;Goodnough;Anesth Analg,2013
2. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial;Roberts;Lancet,2011
3. Antifibrinolytic therapy: new data and new concepts;Levy;Lancet,2010
4. Off-label use of recombinant factor VIIa in U.S. hospitals: analysis of hospital records;Logan;Ann Intern Med,2011
5. Recombinant factor VII is associated with worse survival in complex cardiac surgical patients;Alfirevic;Ann Thorac Surg,2014
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Alternative Factor Prescribing after Low-Dose Recombinant Factor VIIa Protocol in Cardiac Surgery;2022-05-01
2. A role for very low-dose recombinant activated factor VII in refractory bleeding after cardiac surgery: Lessons from an observational study;The Journal of Thoracic and Cardiovascular Surgery;2018-10
3. Conjecture and Fact;Critical Care Medicine;2018-06
4. CON: Factor Concentrates Should Not Have an Expanded Role in the Routine Management of the Bleeding Cardiac Surgical Patient;Journal of Cardiothoracic and Vascular Anesthesia;2018-02
5. Factor VIIa for Annulus Rupture After Transcatheter Aortic Valve Replacement;The Annals of Thoracic Surgery;2015-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3